The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone…
Rigor acadêmico, estilo jornalístico
Todos os artigos de 23andMe
Exibindo 21 - 22 de 22 artigos
Genetic testing is a powerful tool. Two years ago, with the help of my colleagues, it was this tool that helped us identify a new disease. The disease, called Ogden Syndrome, caused the death of a four-month…
Principais colaboradores
-
Research Scientist in Biostatistics, University of Washington
-
Research Professor of Epidemiology, Emory University
-
Academic Fellow, University of Sydney Law School, University of Sydney
-
Research fellow, Western Sydney University
-
Professor of Biology, Boise State University
-
Junior Fellow, MacEachen Institute for Public Policy and Governance; Medical Student, Dalhousie University
-
Lecturer in Psychology and Human Neuroscience, Royal Holloway University of London
-
Ethical, Legal & Social Adviser - Public Health Genomics, Monash University
-
Professor of English, York University, Canada
-
Associate Professor of Population and Statistical Genetics, Hebrew University of Jerusalem
-
Group Leader, Department of Archaeogenetics, Max Planck Institute for Evolutionary Anthropology
-
PhD Candidate, School of Law, Trinity College Dublin
-
Associate Professor of Community Health Sciences, Boston University
-
Professor of Health Law, Public Health Law and Medical Ethics, University of South Florida
-
Research Fellow, University of Exeter
